Gene · 4824
Papers3,429
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,429
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case Report: Cutaneous metastatic mucin-producing prostate adenocarcinoma. | Front Oncol | 2025 | 41293260 | PubTator, text mining | PubMed |
| A Case of Mucous Gland Adenoma of the Lung Representing NKX3.1-Positive Lung Tumour Spectrum. | Respirol Case Rep | 2025 | 41268435 | PubTator, text mining | PubMed |
| Correction: Reciprocal deregulation of NKX3.1 and AURKA axis in castration-resistant prostate cancer and NEPC models. | J Biomed Sci | 2025 | 41207894 | PubTator, text mining | PubMed |
| Crosstalk between decidual natural killer cells and extravillous trophoblasts at the maternal-fetal interface: current status and future perspectives. | Front Immunol | 2025 | 41200190 | PubTator, text mining | PubMed |
Transcriptomics and network pharmacology reveal the potential mechanism related to integrated stress response in the treatment of osteoporosis by Jiawei Shentong Zhuyu Decoction and verified by RT-qPCR. | Front Endocrinol (Lausanne) | 2025 | 41195206 | PubTator, text mining | PubMed |
| Endoscopic Ultrasound With Fine-Needle Biopsy for Rare Pancreatic Metastasis: A Case Series of Neuroendocrine Transformation From Primary Prostate Cancer. | ACG Case Rep J | 2025 | 41181620 | PubTator, text mining | PubMed |
| NKX3-1-Expressing Mucous Gland Adenoma With LMNA::NTRK1 Fusion of the Lung: Toward a Spectrum of NKX3-1-Expressing NTRK-Rearranged Mucinous Neoplasms. | Pathol Int | 2025 | 41126650 | PubTator, text mining | PubMed |
| Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth. | Mol Cancer | 2025 | 41088246 | PubTator, text mining | PubMed |
| Possible role of anastrozole-induced hormonal alterations in pathogenesis of mammary apocrine carcinoma and follicular lymphoma: a case report and review of the literature. | J Med Case Rep | 2025 | 41024216 | PubTator, text mining | PubMed |
| Oesophageal metastasis of prostate cancer: a case report. | Discov Oncol | 2025 | 41003910 | PubTator, text mining | PubMed |
| Antibody-based alternatives to animal testing for toxin detection and antitoxin evaluation. | Front Toxicol | 2025 | 40995337 | PubTator, text mining | PubMed |
| Ubiquitination-activated TAB-TAK1-IKK-NF-κB axis modulates gene expression for cell survival in the lysosomal damage response. | Elife | 2025 | 40990917 | PubTator, text mining | PubMed |
| FET fusion oncoproteins enrich SWI/SNF complex subtypes and interaction partners. | Cell Mol Biol Lett | 2025 | 40988026 | PubTator, text mining | PubMed |
| Metastatic Adenocarcinoma of the Prostate Presenting as a Penile Mass in a Patient With Acute Urinary Retention: A Case Report. | Cureus | 2025 | 40964542 | PubTator, text mining | PubMed |
| Successful Identification and Treatment of Cancer of Unknown Primary Originating From Gastric Cancer Using Comprehensive Genomic Profiling and Immune Checkpoint Inhibitor Therapy: A Case Report. | Cancer Rep (Hoboken) | 2025 | 40916582 | PubTator, text mining | PubMed |
| Targeting TRPV6/CXCR4 complexes prevents castration-resistant prostate cancer metastasis to the bone. | Signal Transduct Target Ther | 2025 | 40908300 | PubTator, text mining | PubMed |
| Toggling of NKG2A expression drives functional specialization of iPSC-derived CAR NK cells. | bioRxiv | 2025 | 40894717 | PubTator, text mining | PubMed |
| Clonal divergence and genomic meltdown in prostatic pleomorphic giant cell adenocarcinoma. | Front Immunol | 2025 | 40873563 | PubTator, text mining | PubMed |
| Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review. | Cells | 2025 | 40862737 | PubTator, text mining | PubMed |
| The utility of next-generation sequencing in metastatic prostate cancer FNA biopsies. | Cancer Cytopathol | 2025 | 40847760 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4824/papers?page=5